Science 1 February 1985: Vol. 227. no. 4686, pp. 484 - 492 DOI: 10.1126/science.2578227

Prev | Table of Contents | Next

Articles

Inhibition of Hepatitis C Virus (HCV) RNA Polymerase by DNA Aptamers: Mechanism of Inhibition of In Vitro RNA Synthesis and Effect on HCV-Infected Cells.

P. Bellecave, C. Cazenave, J. Rumi, C. Staedel, O. Cosnefroy, M.-L. Andreola, M. Ventura, L. Tarrago-Litvak, and T. Astier-Gin (2008)
Antimicrob. Agents Chemother. 52, 2097-2110
 |  Abstract »  |  Full Text »  |  PDF »

Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51.

S. Desfarges, J. San Filippo, M. Fournier, C. Calmels, A. Caumont-Sarcos, S. Litvak, P. Sung, and V. Parissi (2006)
Nucleic Acids Res. 34, 6215-6224
 |  Abstract »  |  Full Text »  |  PDF »

HIV Pathogenesis: Knowledge Gained after Two Decades of Research.

J.A. Levy (2006)
Advances in Dental Research 19, 10-16
 |  Abstract »  |  Full Text »  |  PDF »

Functional Analysis of HIV Type 1 Nef Reveals a Role for PAK2 as a Regulator of Cell Phenotype and Function in the Murine Dendritic Cell Line, DC2.4.

J. Mann, C. N. Patrick, M. S. Cragg, J. Honeychurch, D. A. Mann, and M. Harris (2005)
J. Immunol. 175, 6560-6569
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 Infection.

B. L. Wei, P. W. Denton, E. O'Neill, T. Luo, J. L. Foster, and J. V. Garcia (2005)
J. Virol. 79, 5705-5712
 |  Abstract »  |  Full Text »  |  PDF »

HIV-1 integrase crosslinked oligomers are active in vitro.

A.él. Faure, C. Calmels, Céc. Desjobert, M. Castroviejo, A. Caumont-Sarcos, L. Tarrago-Litvak, S. Litvak, and V. Parissi (2005)
Nucleic Acids Res. 33, 977-986
 |  Abstract »  |  Full Text »  |  PDF »

Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication.

Y.-H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B. M. Peterlin (2004)
J. Virol. 78, 6073-6076
 |  Abstract »  |  Full Text »  |  PDF »

Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages.

J. J. Kohler, D. L. Tuttle, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow (2003)
J. Leukoc. Biol. 73, 407-416
 |  Abstract »  |  Full Text »  |  PDF »

Functional Interactions of Human Immunodeficiency Virus Type 1 Integrase with Human and Yeast HSP60.

V. Parissi, C. Calmels, V. R. De Soultrait, A. Caumont, M. Fournier, S. Chaignepain, and S. Litvak (2001)
J. Virol. 75, 11344-11353
 |  Abstract »  |  Full Text »

Engineering Regulable Escherichia colibeta -Galactosidases as Biosensors for Anti-HIV Antibody Detection in Human Sera.

N. Ferrer-Miralles, J. X. Feliu, S. Vandevuer, A. Muller, J. Cabrera-Crespo, I. Ortmans, F. Hoffmann, D. Cazorla, U. Rinas, M. Prevost, et al. (2001)
J. Biol. Chem. 276, 40087-40095
 |  Abstract »  |  Full Text »  |  PDF »

CD8+ cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration.

C. E. Mackewicz, B. K. Patterson, S. A. Lee, and J. A. Levy (2000)
J. Gen. Virol. 81, 1261-1264
 |  Abstract »  |  Full Text »

High-Level Replication of Human Immunodeficiency Virus in Thymocytes Requires NF-kappa B Activation through Interaction with Thymic Epithelial Cells.

L. Chêne, M.-T. Nugeyre, F. Barré-Sinoussi, and N. Israël (1999)
J. Virol. 73, 2064-2073
 |  Abstract »  |  Full Text »

Molecular and Biotechnological Aspects of Microbial Proteases.

M. B. Rao, A. M. Tanksale, M. S. Ghatge, and V. V. Deshpande (1998)
Microbiol. Mol. Biol. Rev. 62, 597-635
 |  Abstract »  |  Full Text »  |  PDF »

Genotypic Changes in Human Immunodeficiency Virus Type 1 Associated with Loss of Suppression of Plasma Viral RNA Levels in Subjects Treated with Ritonavir (Norvir) Monotherapy.

P. S. Eastman, J. Mittler, R. Kelso, C. Gee, E. Boyer, J. Kolberg, M. Urdea, J. M. Leonard, D. W. Norbeck, H. Mo, et al. (1998)
J. Virol. 72, 5154-5164
 |  Abstract »  |  Full Text »  |  PDF »

Human Immunodeficiency Virus (HIV) Envelope Binds to CXCR4 Independently of CD4, and Binding Can Be Enhanced by Interaction with Soluble CD4 or by HIV Envelope Deglycosylation.

J. C. Bandres, Q. F. Wang, J. O'Leary, F. Baleaux, A. Amara, J. A. Hoxie, S. Zolla-Pazner, and M. K. Gorny (1998)
J. Virol. 72, 2500-2504
 |  Abstract »  |  Full Text »  |  PDF »

Synergistic Activation of Transcription by the Mutant and Wild-type Minimal Transcriptional Activation Domain of VP16.

S. Ghosh, C. Toth, B. M. Peterlin, and E. Seto (1996)
J. Biol. Chem. 271, 9911-9918
 |  Abstract »  |  Full Text »  |  PDF »

Diagnosis of Pediatric Human Immunodeficiency Virus Infection by Means of a Commercially Available Polymerase Chain Reaction Gene Amplification.

R. P. Nelson Jr, L. J. Price, A. B. Halsey, S. N. Graven, L. Resnick, N. K. Day, R. F. Lockey, and R. A. Good (1996)
Arch Pediatr Adolesc Med 150, 40-45
 |  Abstract »  |  PDF »

Biochemical and Genetic Definition of the Cellular Protease Required for HIV-1 gp160 Processing.

A. Franzusoff, A. M. Volpe, D. Josse, S. Pichuantes, and J. R. Wolf (1995)
J. Biol. Chem. 270, 3154-3159
 |  Abstract »  |  Full Text »  |  PDF »

Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

F Dyda, A. Hickman, T. Jenkins, A Engelman, R Craigie, and D. Davies (1994)
Science 266, 1981-1986
 |  Abstract »  |  PDF »

LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.

S Wain-Hobson, J. Vartanian, M Henry, N Chenciner, R Cheynier, S Delassus, L. Martins, M Sala, M. Nugeyre, D Guetard, et al. (1991)
Science 252, 961-965
 |  Abstract »  |  PDF »

Human immunodeficiency virus infection of human-PBL-SCID mice.

D. Mosier, R. Gulizia, S. Baird, D. Wilson, D. Spector, and S. Spector (1991)
Science 251, 791-794
 |  Abstract »  |  PDF »

Antiretroviral Therapy in AIDS.

S. Broder, H. Mitsuya, R. Yarchoan, and G. N. Pavlakis (1990)
Ann Intern Med 113, 604-618
 |  Abstract »  |  PDF »

Differential effects of nef on HIV replication: implications for viral pathogenesis in the host.

C Cheng-Mayer, P Iannello, K Shaw, P. Luciw, and J. Levy (1989)
Science 246, 1629-1632
 |  Abstract »  |  PDF »

Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat..

M J Selby, E S Bain, P A Luciw, and B M Peterlin (1989)
Genes & Dev. 3, 547-558
 |  Abstract »  |  PDF »

Development of disease and virus recovery in transgenic mice containing HIV proviral DNA.

J. Leonard, J. Abramczuk, D. Pezen, R Rutledge, J. Belcher, F Hakim, G Shearer, L Lamperth, W Travis, T Fredrickson, et al. (1988)
Science 242, 1665-1670
 |  Abstract »  |  PDF »

A novel gene of HIV-1, vpu, and its 16-kilodalton product.

K Strebel, T Klimkait, and M. Martin (1988)
Science 241, 1221-1223
 |  Abstract »  |  PDF »

Development and testing of AIDS vaccines.

W. Koff and D. Hoth (1988)
Science 241, 426-432
 |  Abstract »  |  PDF »

HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.

J. Zack, A. Cann, J. Lugo, and I. Chen (1988)
Science 240, 1026-1029
 |  Abstract »  |  PDF »

Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand.

R. Miller (1988)
Science 239, 1420-1422
 |  Abstract »  |  PDF »

Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.

D. Ho, J. Kaplan, I. Rackauskas, and M. Gurney (1988)
Science 239, 1021-1023
 |  Abstract »  |  PDF »

DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

C. Ou, S Kwok, S. Mitchell, D. Mack, J. Sninsky, J. Krebs, P Feorino, D Warfield, and G Schochetman (1988)
Science 239, 295-297
 |  Abstract »  |  PDF »

Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.

J. Gnann Jr, J. McCormick, S Mitchell, J. Nelson, and M. Oldstone (1987)
Science 237, 1346-1349
 |  Abstract »  |  PDF »

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.

M Kowalski, J Potz, L Basiripour, T Dorfman, W. Goh, E Terwilliger, A Dayton, C Rosen, W Haseltine, and J Sodroski (1987)
Science 237, 1351-1355
 |  Abstract »  |  PDF »

Functional interaction and partial homology between human immunodeficiency virus and neuroleukin.

M. Lee, D. Ho, and M. Gurney (1987)
Science 237, 1047-1051
 |  Abstract »  |  PDF »

The sor gene of HIV-1 is required for efficient virus transmission in vitro.

A. Fisher, B Ensoli, L Ivanoff, M Chamberlain, S Petteway, L Ratner, R. Gallo, and F Wong-Staal (1987)
Science 237, 888-893
 |  Abstract »  |  PDF »

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

Y Koyanagi, S Miles, R. Mitsuyasu, J. Merrill, H. Vinters, and I. Chen (1987)
Science 236, 819-822
 |  Abstract »  |  PDF »

Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

W. Farmerie, D. Loeb, N. Casavant, C. Hutchison 3rd, M. Edgell, and R Swanstrom (1987)
Science 236, 305-308
 |  Abstract »  |  PDF »

Expression and characterization of the trans-activator of HTLV-III/LAV virus.

C. Wright, B. Felber, H Paskalis, and G. Pavlakis (1986)
Science 234, 988-992
 |  Abstract »  |  PDF »

Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons.

M. Gurney, S. Heinrich, M. Lee, and H. Yin (1986)
Science 234, 566-574
 |  Abstract »  |  PDF »

Neuroleukin: a lymphokine product of lectin-stimulated T cells.

M. Gurney, B. Apatoff, G. Spear, M. Baumel, J. Antel, M. Bania, and A. Reder (1986)
Science 234, 574-581
 |  Abstract »  |  PDF »

Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.

A. Fisher, L Ratner, H Mitsuya, L. Marselle, M. Harper, S Broder, R. Gallo, and F Wong-Staal (1986)
Science 233, 655-659
 |  Abstract »  |  PDF »

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

B. Hahn, G. Shaw, M. Taylor, R. Redfield, P. Markham, S. Salahuddin, F Wong-Staal, R. Gallo, E. Parks, and W. Parks (1986)
Science 232, 1548-1553
 |  Abstract »  |  PDF »

AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts.

J. Levy, C Cheng-Mayer, D Dina, and P. Luciw (1986)
Science 232, 998-1001
 |  Abstract »  |  PDF »

Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

K. Jones, J. Kadonaga, P. Luciw, and R Tjian (1986)
Science 232, 755-759
 |  Abstract »  |  PDF »

A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses.

T. Lee, J. Coligan, J. Allan, M. McLane, J. Groopman, and M Essex (1986)
Science 231, 1546-1549
 |  Abstract »  |  PDF »

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions.

J Sodroski, W. Goh, C Rosen, A Tartar, D Portetelle, A Burny, and W Haseltine (1986)
Science 231, 1549-1553
 |  Abstract »  |  PDF »

Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera.

N. Kan, G Franchini, F Wong-Staal, G. DuBois, W. Robey, J. Lautenberger, and T. Papas (1986)
Science 231, 1553-1555
 |  Abstract »  |  PDF »

Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein.

R. Kennedy, R. Henkel, D Pauletti, J. Allan, T. Lee, M Essex, and G. Dreesman (1986)
Science 231, 1556-1559
 |  Abstract »  |  PDF »

Nucleotide sequence of SRV-1, a type D simian acquired immune deficiency syndrome retrovirus.

M. Power, P. Marx, M. Bryant, M. Gardner, P. Barr, and P. Luciw (1986)
Science 231, 1567-1572
 |  Abstract »  |  PDF »

HTLV-III gag protein is processed in yeast cells by the virus pol-protease.

R. Kramer, M. Schaber, A. Skalka, K Ganguly, F Wong-Staal, and E. Reddy (1986)
Science 231, 1580-1584
 |  Abstract »  |  PDF »

Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.

R. Stephens, J. Casey, and N. Rice (1986)
Science 231, 589-594
 |  Abstract »  |  PDF »

Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.

S Benn, R Rutledge, T Folks, J Gold, L Baker, J McCormick, P Feorino, P Piot, T Quinn, and M Martin (1985)
Science 230, 949-951
 |  Abstract »  |  PDF »

A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

J. Allan, J. Coligan, T. Lee, M. McLane, P. Kanki, J. Groopman, and M Essex (1985)
Science 230, 810-813
 |  Abstract »  |  PDF »

HTLV-III and LAV: similar, or identical?.

C Norman (1985)
Science 230, 643
 |  PDF »

A Human T-Lymphotropic Retrovirus (HTLV-III) as the Cause of the Acquired Immunodeficiency Syndrome.

R. C. GALLO and F. WONG-STAAL (1985)
Ann Intern Med 103, 679-689
 |  Abstract »  |  PDF »

Prospects of Therapy for Infections with Human T-Lymphotropic Virus Type III.

M. S. HIRSCH and J. C. KAPLAN (1985)
Ann Intern Med 103, 750-755
 |  Abstract »  |  PDF »

Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes.

A. Rabson, D. Daugherty, S Venkatesan, K. Boulukos, S. Benn, T. Folks, P Feorino, and M. Martin (1985)
Science 229, 1388-1390
 |  Abstract »  |  PDF »

Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

F. Veronese, A. DeVico, T. Copeland, S Oroszlan, R. Gallo, and M. Sarngadharan (1985)
Science 229, 1402-1405
 |  Abstract »  |  PDF »

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

F Wong-Staal, G. Shaw, B. Hahn, S. Salahuddin, M Popovic, P Markham, R Redfield, and R. Gallo (1985)
Science 229, 759-762
 |  Abstract »  |  PDF »

Infection With HTLV-III/LAV and Transfusion-Associated Acquired Immunodeficiency Syndrome: Serologic Evidence of an Association.

H. W. Jaffe, M. G. Sarngadharan, A. L. DeVico, L. Bruch, J. P. Getchell, V. S. Kalyanaraman, H. W. Haverkos, R. L. Stoneburner, R. C. Gallo, and J. W. Curran (1985)
JAMA 254, 770-773
 |  Abstract »  |  PDF »

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

S Harada, Y Koyanagi, and N Yamamoto (1985)
Science 229, 563-566
 |  Abstract »  |  PDF »

cis- and trans-acting transcriptional regulation of visna virus.

J. Hess, J. Clements, and O Narayan (1985)
Science 229, 482-485
 |  Abstract »  |  PDF »

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

S. Arya, C Guo, S. Josephs, and F Wong-Staal (1985)
Science 229, 69-73
 |  Abstract »  |  PDF »

Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

J Sodroski, R Patarca, C Rosen, F Wong-Staal, and W Haseltine (1985)
Science 229, 74-77
 |  Abstract »  |  PDF »

Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family.

M Seiki, A Hikikoshi, T Taniguchi, and M Yoshida (1985)
Science 228, 1532-1534
 |  Abstract »  |  PDF »

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.

F Barin, M. McLane, J. Allan, T. Lee, J. Groopman, and M Essex (1985)
Science 228, 1094-1096
 |  Abstract »  |  PDF »

A virus by any other name . ..

J. Marx (1985)
Science 227, 1449-1451
 |  PDF »

Substitutions in a Homologous Region of Extracellular Loop 2 of CXCR4 and CCR5 Alter Coreceptor Activities for HIV-1 Membrane Fusion and Virus Entry.

D. J. Chabot and C. C. Broder (2000)
J. Biol. Chem. 275, 23774-23782
 |  Abstract »  |  Full Text »  |  PDF »

Synergistic Activation of NFAT by HIV-1 Nef and the Ras/MAPK Pathway.

A. Manninen, G. Herma Renkema, and K. Saksela (2000)
J. Biol. Chem. 275, 16513-16517
 |  Abstract »  |  Full Text »  |  PDF »

Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration.

H. C. Ha, K. Juluri, Y. Zhou, S. Leung, M. Hermankova, and S. H. Snyder (2001)
PNAS 98, 3364-3368
 |  Abstract »  |  Full Text »  |  PDF »

HIV envelope gp120 activates human arterial smooth muscle cells.

A. D. Schecter, A. B. Berman, L. Yi, A. Mosoian, C. M. McManus, J. W. Berman, M. E. Klotman, and M. B. Taubman (2001)
PNAS 98, 10142-10147
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products